FDA concerned about some STD medications

Mar 10, 2008

The U.S. Food and Drug Administration has warned six companies to stop marketing unapproved drugs for treating and preventing sexually transmitted diseases.

The FDA said some of the products falsely claim to have received FDA approval, while some claim to be more effective than conventional medicine. The products are sold as Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus.

Officials said the products claim to prevent or treat a variety of STDs, including herpes, chlamydia, human papilloma virus, cervical dysplasia, and HIV/AIDS. The FDA said it considers the products to be unapproved new drugs marketed in violation of the Federal Food, Drug and Cosmetic Act. Officials said the drugs are also misbranded since they lack proper directions for use by consumers and/or make false and misleading claims.

The FDA identified the companies as Aviralex International of San Francisco; Aidance Skincare & Topical Solutions LLC. of Harmony, R.I.; health-science-report.com; NeumaLife of Boys Town, Neb.; IMULUX LLC. of Fort Smith, Ark.; the Saferex Laboratories International Corp. of Sachse, Texas; and Waldon Research of Christchurch, New Zealand.

Copyright 2008 by United Press International

Explore further: FDA approves second vaccine against meningitis strain

add to favorites email to friend print save as pdf

Related Stories

Keeping hackers out of hospitals

Jan 07, 2015

The humble infusion pump: It stands sentinel in the hospital room, injecting patients with measured doses of drugs and writing information to their electronic medical records.

Calcium makes for an environmentally friendly pickle

Jul 08, 2014

George Washington had a collection of 476 kinds of pickles. To prevent scurvy, Christopher Columbus stocked pickles on the NiƱa, Pinta, and Santa Maria. Julius Caesar, believing pickles to be invigorating, ...

Chemists discover structure of cancer drug candidate

May 19, 2014

Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

One of the last strongholds for Western chimpanzees

Apr 09, 2014

When Liberia enters the news it is usually in the context of civil war, economic crisis, poverty or a disease outbreak such as the recent emergence of Ebola in West Africa. Liberia's status as a biodiversity ...

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

herpesdate
not rated yet Mar 11, 2008
Hope the products can prevent or treat a variety of STDs, including herpes, chlamydia, human papilloma virus, cervical dysplasia, and HIV/AIDS. Then it's great news for STDromance.com users

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.